Nanostructured protein materials are gaining interest in biomedicine because of their biocompatibility, easy production and functional versatility. Merging structure and function in proteins allows designing protein composites with refined functions such as cell or tissue targeting. The basis of protein structure and biological activity is the attained spatial conformation, in a process tightly surveyed by the cell factory. However, at which extent the cell's quality control determines the architecture and biological performance of functional protein materials is a neglected issue. We demonstrate here that the activity at the systems level of a tumour-targeted protein-only nanoparticle is dramatically affected by key knock-out mutations in the quality control network of the producing bacteria, resulting in altered biodistribution patterns upon systemic administration. Therefore, since the conformational modulation at the molecular level determines the macroscopic biological performance, a tailored tuning of protein materials' activities might be approachable, in a bottom-up fashion, by the appropriate genetic adjustment of the cell factory's folding machinery.
Since the approval of insulin in 1981, [1] about 400 protein drugs, mainly produced in microbial cells, [2] have been authorized for use in humans. Apart from plain therapeutic cytokines, hormones, enzymes and antibodies, a plethora of more elaborated protein structures with different extents of complexity have been developed as nanoconjugates for drug delivery [3] including nabpaclitaxel, [4] denileukin difitox, [5] PEG-ADA [6] and pegaspargase. [7] Recent developments in the engineering of protein self-assembling [8] and the expanding catalogues of homing peptides [9] offer clues for the design and construction of smart protein nanostructures intended as functional substrates in regenerative medicine [10] or as vehicles for the cell-targeted delivery of payload imaging agents and drugs. [11] Most of these applications are based on specific interactions between peptidic ligands displayed on the material's surface and surface-exposed receptors on the membrane of target cells, as aiming to internalization or signalling. Engineered protein materials are produced, as recombinant versions, in cell factories, mainly bacteria, [12] thus benefiting from the versatility and adaptability of biological fabrication. [13] In recombinant bacteria, disaggregation, folding and refolding, are executed by the quality control system (the chaperone-protease network), to minimize aggregation and to promote proper folding of engineered polypeptides. [14] How the quality control system does handle conventional soluble proteins is rather well stablished. [15] However, the cell's surveillance of bioactive, complex protein nanostructures performing specialized functions is a neglected issue, while it has a pivotal relevance in the context of emerging protein materials. [12] We have here analyzed the influence of the bacterial quality control on hyerarchical structural features and biological performance of smart protein materials of biomedical interest, illustated by a tumor-targeted, self-assembling nanoparticle produced by recombinant methods.
For that, we selected T22-GFP-H6, an engineered polypeptide ( Figure 1A ) that binds the cytokine receptor CXCR4 via the tumor-homing peptide T22. [16] This protein spontaneously self-assembles as nanoparticles of ~15 nm, that as observed by FESEM [17] ( Figure 1B ) organize as regular toroid (ring-shaped) materials,. When systemically administered in colorectal cancer mice models, these particles escape renal filtration and target primary tumour and metastatic foci, through specific internalization in CXCR4 + cells. [17, 18] Both the amino terminal T22 and the carboxy terminal H6 are involved in the interactions between building blocks that support nanoparticle formation. [19] Since T22 folds through two disulphide bonds, the fusion protein has been usually produced in Escherichia coli BL21 Origami B (TrxB -, Gor -) to facilitate disulphide bridge formation in a less reducing environment. [17] To evaluate to which extent the protein production/folding machinery might have an impact on protein self-assembling and thus influence architectonic features and function of T22-GFP-H6 nanoparticles, the building block was produced in E. coli K-12 strains with knock-outed critical agents critical in different arms of the protein quality control. For that, we selected the main negative regulator of the whole quality control system and main disaggregase/foldase (the chaperone DnaK, JGT20 strain), the versatile ATPase ClpA (JGT4 strain) involved in ATPdependent processes related with protein management, and the key cytosolic protease ClpP (JGT19 strain) that degrades misfolding-prone proteins. [20] As expected, recombinant proteins produced in these mutants exhibit altered proteolytic stability, solubility, aggregation profile and biological activity [20] .
T22-GFP-H6 was also synthesized in the parental MC4100 ara-D139 Δ(argFlac)U169 rpsL150 relA1 flbB5301 deoC1 ptsF25 rbsR). Origami B was kept as a reference for its ability to favour disulphide bridge formation. In all these strains, proteins were produced intracellularly and further purified from bacterial extracts by His-tag affinity chromatography. This resulted in the protein eluted into two separated peaks (P1 and P2, Supplementary Interestingly, there were no significant differences in the size (measured by DLS) and superficial charge (measured as Zeta potential) of the produced materials ( Figure 1E, F) , although P1 particles were slightly smaller than those found in P2 (an average of around 14 nm versus 16 nm). TEM and FESEM images confirmed the regular size and the ring-shaped nanoparticle organization, but also the slight differences between the material size in P1 and P2 fractions (Figure 2A ). This indicated a robust self-assembling of building blocks, resulting in similar oligomers and oligomer-oligomer interactions irrespective of the strain used as factory. Despite the homogeneous geometry, the penetrability into CXCR4 + HeLa cells was dramatically influenced by the genetic background, showing a wide variability when comparing data between bacterial strains. In addition, the uptake of P2 fractions was generally higher than that of P1's in the MC4100 background ( Figure 2B ). This fact supported the occurrence of conformational protein variants mostly represented by P1 and P2 subpopulations but also modulated by the performance of the quality control in particular strains. While exhibiting similar geometries once assembled, the T22-homing peptide and the H6 tail of T22-GFP-H6 might be more available for cross-molecular interactions (with CXCR4 and Ni 2+ respectively) in P2 than in P1 particles. H6, being a purification tag, is also a powerful endosomal escape agent [21] , and its enhanced display would favour not only protein purification but also stability of internalized nanoparticles, as it seems to occur in P2 materials.
To identify any relevant physicochemical properties of the material that might influence cell penetrability we confronted internalization data ( Figure 2B Figure 2C ). In this regard, some particle variants, mostly represented (but not exclusively) by P1, exhibited a specific fluorescence emission higher than the parental, unassembled protein GFP-H6, that was estimated to be 7,584 ± 834 Units/mg under the same recording settings. This indicated that the assembling of conformational isoforms of the building block might activate the GFP chromophore through particular cross-molecular interactions. Such particular architecture would restrict the solvent exposure of both end terminal tails. Nanoparticle versions with more exposed tails might be instead equally or slightly less fluorescent than the wild type GFP-H6.
This possibility was explored by modelling T22-GFP-H6 nanoparticles, resulting in two models that best fitted microscopic images and size measures (P1 and P2 in Figure 2D ). P1 was characterized by less exposed terminal tails ( Figure   2D , bottom) and by inter-molecular interactions between the overhanging ligand T22 and residues H148, M154, V163, V164, I167, S202, T203, E222 (amino acid numbering from [22] ) of the adjacent GFP barrel ( Figure 2E ). These residues have been previously reported as involved in the modulation of the intensity of the fluorescence emission, [23] supporting the idea that T22 could modify their molecular environment, enhancing the fluorescence activity of GFP.
[ 24, 25] In P2 materials, terminal tails are more available to external interactors and the GFP chromophore remains unaffected by internal cross-molecular contacts. Interestingly, the diameter of the modelled particles, which was not used as a modelling restraint, was 14.1 nm for P1 and 16.7 nm for P2, close to the experimental diameters and with a very similar difference (about 3 nm) between them. When exploring the set of (differently) cell-internalizing P2 particles, the suspected variability in the conformation of building blocks even within a single peak ( Figure 2C ) was confirmed by comparing the signal intensity at 218 nm on circular dichroism spectrum, where greater beta-sheet secondary structure signal is displayed by more compacted conformations
Geometry (size and shape) and charge of nanostructured materials administered systemically determine cell penetrability, local diffusion and biodistribution [26] . Being these parameters essentially homogeneous among the set of nanoparticles generated here, the potential of T22-GFP-H6 to bind and internalize CXCR4+ cells in vitro is modulated by subtle conformational differences in the building blocks. To asses if the variable uptake in vitro could also influence the in vivo performance of the material, the biodistribution of P2 nanoparticles (those among the whole set, exhibiting efficient cell uptake in vitro) was evaluated in CXCR4 + colorectal mouse models upon systemic administration. Under the homogeneous geometry of the P2 particle set, any altered biodistribution map should be uniquely attributed to fine structural variability determined by the bacterial genetic background. No fluorescence was observed in kidney or lung in any case, indicative of high stability of all particle isoforms, which remained assembled and dispersed in vivo ( Table 1 ). The French press (Thermo FA-078A) and proteins were purified by His tag-affinity chromatography using 1 mL HiTrap Chelating HP column (GE Healthcare, Piscataway, NJ) through an AKTA purifier FPLC (GE Healthcare). Separations were made by linear gradient of Tris 20 mM, pH 8.0, 500 mM NaCl, and 500 mM imidazole. Fractions collected were dialyzed against NaHCO3 160mM pH 7.4 Buffer.
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Protein amounts were determined by Bradford's assay [2] and analyzed by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) and anti-GFP western blot.
Fluorescence, size particle and zeta potential. Fluorescence of purified protein was measured in a spectrometer Cary Eclipse (Varian, Mulgrave Australia) using 1 ml cuvettes, at 450 nm of excitation wavelength and 510 nm of emission wavelength.
The volume and size distribution of nanoparticles in buffer NaHCO3, as well as zeta potential, were measured by dynamic light scattering at 633 nm through a Zetasizer Nano ZS (Malvern Instruments Limited, Malvern, Worcestershire, UK) using disposable plastic cuvettes. Nanoparticles samples were analyzed by triplicate averaging fifteen single measurements.
Electron microscopy. Nanoparticles were analysed by transmission electron microscopy (TEM) and field emission scanning electron microscopy (FESEM). For TEM, protein samples were negatively stained with uranyl acetate by conventional methods [3] and observed in a Jeol 1400 microscope operating at 80 kV and Modelling. The T22GFPH6 monomer was modelled by homology using Modeler 9v13 [4] and the following templates: the peptide polyphemusin I structure (pdb code 1RKK model 1) [5] for T22 (T22-GFP-H6 residues 2 to 19; 74 % identity); residues 40 to 49 of the globular domain of Gallus gallus histone H5 (pdb code 1HST) [6] (residues 17 to 26; 80 % identity) and the structure with pdb code 1QYO for GFP [7] (residues 27 to 262; 98 % identity). The histidine tail was modelled by Modeller's automodel function (residues 263 to 269). 500 models were generated and sorted by their DOPE score. [8] Models with "knots" [9] were removed and the one with the best per-residue score was selected. 20 models with best DOPE score were analysed with the Electrostatic-Desolvation-Profile method, [10] after removal of the N and C terminal tails, to predict the binding patch in the T22-GFP-GFP barrel.
Residues from the patch with a surface accessible area greater than 40 % were used as Ambiguous Interaction Restraints (AIR) in HADDOCK. Those in the center of the patch, which were also more frequently predicted by EDP ( Figure 2E ), were selected as active residues while the rest were used as passive.
To construct the nanoparticle models several runs of HADDOCK were performed, enforcing C5 symmetry and using different active and passive residues as AIR. Three different combinations where used: T22-tail residues (1 to 25 in the T22-GFP-H6 monomer) as actives and His-tail residues (262 to 269) as passives; only T22 residues as actives; T22-tail residues as actives and EDP-predicted residues as actives and passives as previously explained. Histidines were protonated according to their pKas and pH 7.4 (same used for microscopy sample preparation) using the protonate3D [11] function from the MOE package. [12] All generated models where clustered as explained in the HADDOCK tutorial [13] and visually inspected with Rasmol [14] , which was also used for measurements. 3D representations shown in figures have been generated with UCSF Chimera. [15] Diameters were calculated using the two barrel alpha-carbons farthest apart in the oligomer structure. Histological and immunohistochemical (IHC) analysis. Tumors were fixed and paraffin-embedded, cut into 4 m sections, processed as previously described [3, 16] and H&E stained for histological analysis by two independent observers. CXCR4
membrane expression and nanoparticle cell internalization in tumor and normal tissues was assessed by IHC using primary anti-CXCR4 (1:300; Abcam, UK) or anti-GFP (1:100; Santa Cruz Biotechnology, USA), and secondary HRP conjugated antibody, followed by chromogenic detection. [3] The percent of CXCR4-expressing cells in relation to the total cell number and their staining intensity was cuantified, scoring each from 0 to 3 (where 3 is the maximal intensity) and multiplying both values to obtain the H-score.
Supplementary Figure 1. Protein purification and preliminary characterization. A)
Two protein peaks (P1 & P2) were observed in the separation of T22-GFP-H6 produced in different E. coli strains, by affinity chromatography against an imidazole concentration gradient. B) MS spectra of T22-GF-PH6 eluted in P2. Except for Origami B, the materials from all strains separated into two major peaks corresponding to the molecular weight of the full-length T22-GFP-H6 (30.6 KDa) and to a shorter species (~28.5 KDa). C) Circular Dichroism spectra from 260 nm to 205 nm of T22-GFP-H6 of P2 materials produced in different strains. A peak at 218 nm is observed corresponding to beta-sheet secondary structure signal.
